Volume : 09, Issue : 10, October – 2022

Title:

49.STABILITY INDICATING RP HPLC METHOD DEVELOPMENT AND VALIDATION FOR ESTIMATION OF DALFAMPRIDINE IN ITS BULK AND FORMULATION

Authors :

B. Bharath Kumar, Dr. Balaji

Abstract :

A simple and selective LC method is described for the determination of DALFAMPRIDINE tablet dosage forms. Chromatographic separation was achieved on a c18 column using mobile phase consisting of a mixture of MixedPhosphate buffer (KH2PO4+K2HPO4) pH:3.5 Acetonitrile (30:70v/v/v), with detection of 244 nm. Linearity was observed in the range 35-105 µg /ml for DALFAMPRIDINE (r2 =0.998) for drugs estimated by the proposed methods was in good agreement with the label claim. Several analytical procedures have been proposed for the quantitative estimation of DALFAMPRIDINE separately and in combination with other drugs. To my knowledge simple, rapid analytical method for determination of DALFAMPRIDINE has not been reported so far. So attempt was taken to develop and validate a reversed-phase high performance liquid chromatographic method for the quality control of DALFAMPRIDINE in pharmaceutical preparations with lower solvent consumption along with the short analytical run time that leads to an environmentally friendly chromatographic procedure and will allow the analysis of a large number of samples in a short period of time.
Keywords: Dalfampridine, RP‐HPLC, Method development, Validation

Cite This Article:

Please cite this article in press Balaji et al, Stability Indicating RP HPLC Method Development And Validation For Estimation Of Dalfampridine In Its Bulk And Formulation., Indo Am. J. P. Sci, 2022; 09(10).

References:

1. McDonald S, Clements JN (2011) Dalfampridine: a new agent for symptomatic management of multiple sclerosis. Am J Health Syst Pharm 68(24):2335–2340. https://doi.org/10.2146/ajhp110134
2. Tsang BK, Macdonell R (2011) Multiple sclerosis – diagnosis, management and prognosis. Reprints from Australian family physician. Focus Neurol 40(12):948–955
3. National Center for Biotechnology Information. PubChem database. 4- Aminopyridine, CID=1727. https://pubchem.ncbi.nlm.nih.gov/compound/4-a minopyridine. Accessed 1 Mar 2020
4. Madhumathi CH, Padmalatha M, Sneha D (2014) Development and validation of UV spectrometric method for the estimation of Dalfampridine in tablets. Int J Innov Pharm Sci Res 2(5):1019–1026
5. Redasan VK, Gazala LS, Surana SJ (2014) Development and validation of spectroscopic method for the estimation of Dalfampridine in bulk and in tablet formulation. Anal Chem Ind J 14(1):37–41
6. Raut, G; Shirkhedkar, A; Ugale, V; and Surana, S. (2014) Simultaneous determination of prednisolone acetate and moxifloxacin hydrochloride in bulk and in eye drop using RP–HPTLC. J Liquid Chromatogr Relat Technol 37:528–537.6. https://doi.org/10.1080/10826076.2012.749495, 4
7. Bendale AR, Narkhede SP, Palande S, Nagar AA, Vidyasagar GL (2013) Validated RP-HPLC method as a tool for estimation of lornoxicam in pharmaceutical dosage form. Indo Am J Pharm Res 3(7):5491–5498
8. Sethi PD, Sethi R (2007) High performance liquid chromatography, quantitative analysis of pharmaceutical formulation. CBS Publishers and Distributors, pp 2–7
9. Nagar A, Chugh N (2015) Simultaneous estimation method development as analytical method for flupentixol dihydrochloride and melitracen HCl from their combined pharmaceutical dosage forms by RP-HPLC. Pharm Innov J 4(1):81–86
10. EL-Fatatry HM, Hammad SF, Elagamy SH (2013) Validation of spectrofluorimetric determination of Dalfampridine in its synthetic mixture and spiked human plasma through derivatization with fluorescamine. J Anal Tech 3(1):23–26
11. Nagar A, Deore S, Bendale A, Kakade R, Sonawane C (2020) Analytical method development and validation of Ramipril and Candesartan Cillexetil in synthetic mixture. Innov Pharm Pharmacother 8(2):14–20. https://doi. org/10.31690/ipp.2020.v08i02.001